ARPC1B’s effects on diabetes are not limited to immune responses; studies have shown that ARPC1B is a substrate of PAK1 during mitosis (45), and changes in PAK1 levels regulate the tissue crosstalk of pancreatic β cells, affecting systemic glucose homeostasis (46). Here, PAK1 is linked to diabetes mellitus.